Abstract:Background It is unclear whether high‐sensitivity troponin T (hs‐TnT) is associated with subclinical cardiac changes in chronic kidney disease (CKD). We evaluated the relationship between hs‐TnT and left ventricular structure and function in a CKD population, according to estimated glomerular filtration rate. Methods and Results We analyzed 2017 patients with CKD stages 1 to 5 (predialysis) in the KNOW‐CKD (Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease) cohort. The predictor was hs‐TnT level measured at baseline, and the outcomes were left ventricular hypertrophy (LVH) and systolic and diastolic dysfunction shown by echocardiography at baseline and after 4 years. Participants were categorized into quartiles according to hs‐TnT levels. The associations between quartiles of hs‐TnT and outcomes were assessed using multivariable logistic regression analysis with confounders including demographics, medical history, and laboratory findings. A receiver operating characteristic curve was used to assess the diagnostic power of hs‐TnT for the outcomes as a continuous variable. For subgroup analysis, patients were stratified based on an estimated glomerular filtration rate of 60 mL/min per 1.73 m 2 . Elevated hs‐TnT was associated with LVH and diastolic dysfunction at baseline in an adjusted model but was not associated with systolic dysfunction. These associations remained significant for both estimated glomerular filtration rate subgroups. Receiver operating characteristic curve analysis showed that hs‐TnT as a continuous variable exhibited fair significance for detection of LVH (area under the curve: 0.689) and diastolic dysfunction (area under the curve: 0.744). Multivariable analysis showed that higher hs‐TnT levels at baseline were related to development of LVH but not diastolic dysfunction (n=864). Conclusions In CKD patients, hs‐TnT is strongly associated with alterations of left ventricular structure and diastolic dysfunction for both estimated glomerular filtration rate strata. Baseline hs‐TnT levels are predictive of new LVH on follow‐up. Clinical Perspective What Is New? In patients with chronic kidney disease, high‐sensitivity troponin T (TnT) is strongly associated with alterations of left ventricular structure and diastolic dysfunction, regardless of estimated glomerular filtration rate strata. Baseline levels of high‐sensitivity TnT are predictive of new left ventricular hypertrophy on follow‐up. What Are the Clinical Implications? This research suggests that a high‐sensitivity TnT assay could be a useful targeted strategy for risk stratification of patients who may need further cardiac evaluation, regardless of renal function. Further studies are needed to confirm the ideal cutoff values for high‐sensitivity TnT in chronic kidney disease. Introduction Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). It is important to identify risk factors for prevention of cardiovascular disease in patients with CKD to facilitate treatment in the asymptomatic phase. Although pathologic changes in cardiac structure including left ventricular hypertrophy (LVH) may affect cardiovascular mortality, 1 , 2 they do not produce definite cardiac symptoms. For these reasons, physicians and researchers have invested considerable effort into identifying biomarkers related to subclinical changes in cardiac structure. The conventional cardiac troponin T (TnT) assay has become a widely used biomarker for diagnosing acute coronary syndrome. 3 Troponin assays have continued to evolve, and a high‐sensitivity TnT (hs‐TnT) assay with detection limits 10 to 100 times lower than conventional assays is now available. Importantly, hs‐TnT can be detected in asymptomatic patients with no history of cardiovascular disease. Chronically elevated levels of hs‐TnT were recently shown to be associated with chronic subclinical myocardial damage in the general population, including left ventricular (LV) structure abnormalities. 4 , 5 , <a class="tab-link" href="#jah34438-bib-000 -Abstract Truncated-

Study of Cardiac Troponin T Assay in Asymptomatic Patients with Chronic Renal Failure

Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC)

High-Sensitivity Cardiac Troponin T Assessment to Improve Cardiovascular Risk Prognostication in Patients with Chronic Kidney Disease: Ready for Prime Time?

High-sensitive cardiac troponin for the diagnosis of acute myocardial infarction in different chronic kidney disease stages

The Impact of Serum Cystatin C on Short Term Prognosis in Petients With Ischemic Heart Failure

Relationship Between Serum cTnI/cTnT in Patients with Chronic Heart Failure and Different Cardiovascular Diseases

Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.

Diagnosis of Acute Myocardial Infarction in Patients with Renal Insufficiency Using High-Sensitivity Troponin T

Assessment of serum cardiac troponin T and C-reactive protein in predicting hemodialysis outcome

Cardiac Troponin Levels in Patients with Chronic Kidney Disease: "Markers of High Risk or Just Noise''?

Influence factors of serum high-sensitivity cardiac troponin T among chronic kidney disease patients

Diagnostic value of high sensitivity cardiac troponin T (hs-cTnT) in dialysis patients with myocardial infarction

Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T

Diagnosis of Acute Myocardial Infarction in Hemodialysis Patients with High-Sensitivity Cardiac Troponin T Assay.

Association of serum cardiac troponin I and severity of coronary stenosis in patients with varied renal functions: a retrospective cohort study

Interaction mechanisms of encapsulated meningococci with eucaryotic cells: what does this tell us about the crossing of the blood-brain barrier by Neisseria meningitidis?

Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect?

The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.

The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease

Acute Kidney Injury and High-Sensitivity Cardiac Troponin T Levels in the Emergency Department